Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-09-26Clinical Trial Update: Study With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF) [Phase 3]
Phase 3 MOTIF trial evaluating modafinil in metastatic breast or prostate cancer patients treated with docetaxel-based chemotherapy; the stu…
-
CLINICAL_TRIALS trial_result · 2012-09-26Clinical Trial Update: Study of Ductal Lavage in Women at High Risk for Breast Cancer
The completed clinical trial NCT00429988, sponsored by the University of California, San Francisco, evaluated ductal lavage in women at high…
-
CLINICAL_TRIALS trial_result · 2012-09-26Clinical Trial Update: Comparison of Two Types of Biopsy in Patients With Breast Lesions [NA]
This clinical trial update reports on a completed study comparing two biopsy methods in patients with breast cancer.
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of doxorubicin and docetaxel in women with stage III breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion status of a Phase 1/Phase 2 study evaluating lapatinib in combination with docetaxel for H…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2) [Phase 3]
Phase 3 trial (RIBBON 2) assessed bevacizumab in combination with chemotherapy for previously treated metastatic breast cancer; the study is…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Isoflavones in Treating Women Who Have Breast Cancer and Are Planning to Undergo Mastectomy or Lumpectomy [NA]
The clinical trial evaluating isoflavones in women with breast cancer planning mastectomy or lumpectomy was terminated. No results are provi…
-
CLINICAL_TRIALS trial_result · 2012-09-21Clinical Trial Update: Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer [Phase 2]
Phase 2 trial updating weekly gemcitabine, epirubicin, and docetaxel in locally advanced or inflammatory breast cancer completed with posted…
-
CLINICAL_TRIALS trial_result · 2012-09-20Clinical Trial Update: Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients
A terminated clinical trial evaluating the safety of exemestane after 2-3 years of adjuvant tamoxifen in postmenopausal patients with early …
-
CLINICAL_TRIALS trial_result · 2012-09-19Clinical Trial Update: Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer [Phase 1]
This Phase 1 trial evaluated the combination of lapatinib and temozolomide for progressive brain metastases in HER2-positive metastatic brea…
-
CLINICAL_TRIALS trial_result · 2012-09-17Clinical Trial Update: Herbal Therapy in Treating Women With Metastatic Breast Cancer [Phase 1, Phase 2]
A completed Phase 1/Phase 2 trial evaluating an herbal therapy in women with metastatic breast cancer. The study was sponsored by the Univer…
-
CLINICAL_TRIALS trial_result · 2012-09-14Clinical Trial Update: Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast Cancer [Phase 2]
This Phase 2 trial evaluated three docetaxel-based regimens plus bevacizumab, with or without trastuzumab, as adjuvant therapy for breast ca…
-
CLINICAL_TRIALS trial_result · 2012-09-14Clinical Trial Update: Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption? [Phase 4]
A Phase 4 trial evaluated whether aromatase inhibitors alter intestinal calcium absorption and related bone health outcomes in people with b…
-
CLINICAL_TRIALS trial_result · 2012-09-13Clinical Trial Update: Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12 [Phase 2]
Phase 2 adjuvant therapy trial in high-risk breast cancer combining weekly doxorubicin and oral cyclophosphamide with G-CSF for 12 weeks and…
-
CLINICAL_TRIALS trial_result · 2012-09-13Clinical Trial Update: Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating weekly vinorelbine in combination with oral capecitabine for stage IV breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-13Clinical Trial Update: A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer [Phase 3]
A phase 3 trial comparing pertuzumab + trastuzumab + docetaxel versus placebo + trastuzumab + docetaxel in previously untreated HER2-positiv…
-
CLINICAL_TRIALS trial_result · 2012-09-13Clinical Trial Update: Home-based Compression Therapy for Arm and Truncal Lymphedema in Breast Cancer [NA]
A completed clinical trial evaluated home-based compression therapy for arm and truncal lymphedema in breast cancer patients. The trial resu…
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer [Phase 1]
Phase 1 trial evaluating the combination of lonafarnib, trastuzumab, and paclitaxel in HER2-overexpressing stage IIIB/IIIC or stage IV breas…
-
CLINICAL_TRIALS trial_result · 2012-09-11Clinical Trial Update: Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating endocrine therapy plus OSI-906, with or without erlotinib, for hormone-sensitive metastatic breast cancer was ter…
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Effect of a Low-Calorie Diet and/or Exercise Program on Risk Factors for Developing Breast Cancer in Overweight or Obese Postmenopausal Women [NA]
This document reports the completion of a clinical trial evaluating whether a low-calorie diet and/or an exercise program influence risk fac…
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Comparison of Diagnostic Performance of an Algorithm and a High Definition Classical Iterative Algorithm Positron Emission Tomography (PET) to 18Fluoro-deoxy-glucose (18FDG) in the Evaluation of Axillary Lymph Node Invasion of Breast Tumors
This trial compared the diagnostic performance of a high-definition iterative PET algorithm to an alternative PET method against 18F-FDG in …
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Family Quality of Life Among Families With a Member Who is a Cancer Patient
A completed ClinicalTrials.gov study from Vanderbilt-Ingram Cancer Center assessing family quality of life in households with a member who h…
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Study to Investigate Adherence of Patients to Clodronate (Bonefos) Treatment
This completed clinical trial evaluated how well patients adhered to clodronate (Bonefos) therapy across several indications including breas…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment [Phase 3]
Phase 3 trial update comparing Arimidex (anastrozole) and tamoxifen in premenopausal women with breast cancer under anti-hormonal treatment;…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies [Phase 1]
Phase 1 safety study of a liposomal docetaxel formulation in patients with solid tumors who have failed prior therapy has been completed, ev…